<p>拜耳股份公司 (ETR:BAYN - 獲取免費報告) 在週三的交易中下跌了 1.9%。該公司交易最低為€36.88，最後交易價格為€37.74。在交易過程中，約有 3,185,697 股易手。該股票此前收盤價為€38.47。</p>
<h2>拜耳股份公司下跌 1.9%</h2>
<ul>
<li>2020 年最佳農業股票推薦</li>
</ul>
<p>該公司的 50 日移動平均為€42.55，200 日移動平均為€34.88。公司的流動比率為 1.00，速動比率為 0.72，債務與股本比率為 144.30。該股票的市值為 3810 億美元，市盈率為-43.30，市盈增長比率為 36.39，貝塔值為 0.93。</p>
<h2>拜耳股份公司簡介</h2>
<p>(獲取免費報告)</p>
<p>拜耳股份公司及其子公司在全球範圍內作為一家生命科學公司運營。它通過製藥、消費者健康和作物科學三個部門進行業務。製藥部門主要提供心臟病學和女性健康護理的處方產品；在腫瘤學、血液學和眼科領域的專業治療藥物；以及診斷成像設備和數字解決方案、對比劑，以及細胞和基因治療。消費者健康部門則銷售非處方藥物用於自我用藥和自我護理；以及營養補充劑、過敏、咳嗽和感冒、皮膚病、疼痛和心血管風險預防、消化健康的解決方案。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們認為比拜耳股份公司更好的股票</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在拜耳股份公司嗎？</h2>
<p>在你考慮拜耳股份公司之前，你需要聽聽這個。</p>
<p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而拜耳股份公司並不在名單上。</p>
<p>雖然拜耳股份公司目前在分析師中被評為持有，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

BAYN

拜耳(ADR)

<p>拜耳股份公司 (ETR:BAYN) 的股票在週三交易中下跌了 1.9%，收於 37.74 歐元，最低曾達到 36.88 歐元。大約交易了 320 萬股，該股票此前收於 38.47 歐元。該公司的市值為 381 億美元，業務涵蓋製藥、消費者健康和作物科學。分析師目前對拜耳的評級為持有，但建議其他股票可能是更好的投資選擇</p>

<p>Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) dropped 1.9% during trading on Wednesday . The company traded as low as €36.88 and last traded at €37.74. Approximately 3,185,697 shares changed hands during trading, The stock had previously closed at €38.47.</p>
<div class="lb-trans"><p>拜耳股份公司 (ETR:BAYN - 獲取免費報告) 在週三的交易中下跌了 1.9%。該公司交易最低為€36.88，最後交易價格為€37.74。在交易過程中，約有 3,185,697 股易手。該股票此前收盤價為€38.47。</p>
</div><h2>Bayer Aktiengesellschaft Trading Down 1.9%</h2>
<div class="lb-trans"><h2>拜耳股份公司下跌 1.9%</h2>
</div><ul>
<li>Best Agriculture Stocks to Buy in 2020</li>
</ul>
<div class="lb-trans"><ul>
<li>2020 年最佳農業股票推薦</li>
</ul>
</div><p>The company has a fifty day moving average of €42.55 and a two-hundred day moving average of €34.88. The company has a current ratio of 1.00, a quick ratio of 0.72 and a debt-to-equity ratio of 144.30. The stock has a market capitalization of $38.10 billion, a price-to-earnings ratio of -43.30, a price-to-earnings-growth ratio of 36.39 and a beta of 0.93.</p>
<div class="lb-trans"><p>該公司的 50 日移動平均為€42.55，200 日移動平均為€34.88。公司的流動比率為 1.00，速動比率為 0.72，債務與股本比率為 144.30。該股票的市值為 3810 億美元，市盈率為-43.30，市盈增長比率為 36.39，貝塔值為 0.93。</p>
</div><h2>Bayer Aktiengesellschaft Company Profile</h2>
<div class="lb-trans"><h2>拜耳股份公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.</p>
<div class="lb-trans"><p>拜耳股份公司及其子公司在全球範圍內作為一家生命科學公司運營。它通過製藥、消費者健康和作物科學三個部門進行業務。製藥部門主要提供心臟病學和女性健康護理的處方產品；在腫瘤學、血液學和眼科領域的專業治療藥物；以及診斷成像設備和數字解決方案、對比劑，以及細胞和基因治療。消費者健康部門則銷售非處方藥物用於自我用藥和自我護理；以及營養補充劑、過敏、咳嗽和感冒、皮膚病、疼痛和心血管風險預防、消化健康的解決方案。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Bayer Aktiengesellschaft</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比拜耳股份公司更好的股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bayer Aktiengesellschaft Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在拜耳股份公司嗎？</h2>
</div><p>Before you consider Bayer Aktiengesellschaft, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮拜耳股份公司之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟蹤華爾街頂級評級和表現最佳的研究分析師及其每日推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而拜耳股份公司並不在名單上。</p>
</div><p>While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然拜耳股份公司目前在分析師中被評為持有，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

拜耳股份公司（ETR:BAYN）股價下跌 1.9% - 這是怎麼回事